Phase 1 Cognitive Decline Clinical Trials
5 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–5 of 5 trials
Recruiting
Phase 1Phase 2
FACE Phase II (a Stage II Trial)
MCIMild Behavioral ImpairmentSubjective Cognitive Decline (SCD)
Stanford University80 enrolled1 locationNCT07130669
Recruiting
Phase 1Phase 2
RAGE Inhibition to Decrease Cardiotoxicity in Women With Early Breast Cancer
Cancer Related Cognitive DeclineNon-metastatic Breast Cancer
Georgetown University48 enrolled3 locationsNCT05256745
Not Yet Recruiting
Phase 1
The MENOCOG Trial: Feasibility, acceptability, and safety of creatine monohydrate supplementation for cognitive function and mood in postmenopausal females with subjective cognitive decline: a randomised, double-blind, placebo-controlled, parallel-group trial
PostmenopauseSubjective Cognitive Decline
Western Sydney University86 enrolled1 locationACTRN12625001344482
Recruiting
Phase 1
Door-Through-Door Companion Rideshare Technology for Individuals With Alzheimer's Disease and Related Dementias (AD/ADRD)
DementiaCognitive DeclineAlzheimer Disease or Associated Disorder
Onward Health, Inc120 enrolled1 locationNCT06850870
Recruiting
Phase 1
Acute Effects of THC in Older Adult
Age-related Cognitive Decline
Yale University60 enrolled1 locationNCT06948136